Detailed Narrative
Q4 FY26 and Full Year FY26 Performance Overview
Jyothy Labs reported Q4 FY26 revenue of INR717 crores, marking a 7.7% year-on-year increase. For the full fiscal year 2026, the company achieved revenues of INR2,944 crores, growing 3.5% in value terms and 6% in volumes. Despite a volatile FMCG environment and elevated input costs, the company maintained steady volume growth, supported by strategic grammage actions and a gradual improvement in demand during the second half of the financial year.
Profitability Impacted by Input Costs and Competition
The company's profitability faced headwinds in Q4 FY26, with gross margin at 45.2%, down 400 basis points year-on-year, and EBITDA margin at 13.5%, a 330 basis point decline. This was primarily driven by sharp increases in crude-linked input costs such as LAB, PP, and PE, which account for 50-60% of inputs, and packaging costs (15-20% of material costs). Management noted a typical 2-3 month lag between cost increases and pricing actions, expecting continued margin pressure in Q1 FY27.
Segmental Growth Dynamics
Fabric Care demonstrated strong growth in Q4 FY26, with 14.4% value and 17.8% volume growth, driven by liquid detergents. Personal Care also showed a robust recovery, achieving 20% growth in both value and volume in Q4, with the Margo franchise performing well. The Household Insecticides (HI) segment saw a 3% value growth in Q4 and significantly reduced its full-year losses from INR25 crores to INR5 crores, moving closer to profitability ahead of schedule.
Competitive Landscape and Pricing Strategies
The Dishwash segment experienced intense competition, leading to flat value growth in Q4 despite a 5% volume increase, due to price reductions and higher grammage. Jyothy Labs launched Exo Liquid, differentiated by bio-enzymes, to compete directly with market leaders and offer an upgrade path for Exo bar users. The company maintains its market share across categories by ensuring competitive pricing and focusing on brand quality and differentiation.
Capital Allocation and M&A Outlook
Jyothy Labs maintains a strong financial position, being debt-free with a cash balance of INR1,000 crores. The Board recommended a final dividend of INR3.5 per share for FY26. The company is actively scouting for suitable M&A targets that align with its strategic goals and add shareholder value, confirming active dialogues with potential targets. Capex for FY27 is expected to be similar to the previous year, and the tax rate is projected to be 25-26%.
Future Outlook and Market Conditions
Management anticipates FY27 to be a stronger year, with a focus on scaling new product developments, improving general trade productivity, and sustaining volume growth amidst price hikes. However, uncertainty persists regarding demand conditions and input costs, making it difficult to provide specific margin guidance for FY27. The company expects the gap between volume and value growth to narrow down and slowly converge due to strategic pricing actions.